1-6 of 6
Linda Lam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Terraflow, a New High Parameter Data Analysis Tool, Reveals Systemic T-Cell Exhaustion and Dysfunctional Cytokine Production in Classical Hodgkin Lymphoma

Dan Freeman, Linda Lam, Tri Li, Jason Alexandre, Bruce G. Raphael, David Kaminetzky, Jia Ruan, Pratip Chattopadhyay, Catherine S. Diefenbach
Journal: Blood
Blood (2021) 138 (Supplement 1): 3516.
https://doi.org/10.1182/blood-2021-149154
Published: 2021
Journal Articles

Evaluation of the Functional Landscape of Systemic Immunity in Classical Hodgkin Using a Novel Single Cell Platform (Isolight)

Catherine Diefenbach, MD, Linda Lam, PhD, Bruce G. Raphael, MD, Kenneth B. Hymes, MD, Michael L. Grossbard, MD, Tibor Moskovits, MD, Peter Martin, FRCPC, MD MS, Jia Ruan, MD PhD, John P. Leonard, MD, Pratip Chattopadhyay, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3980.
https://doi.org/10.1182/blood-2019-128366
Published: 2019
Journal Articles

Selection and Characterization of Antibody Clones Are Critical for Accurate Flow Cytometry-Based Monitoring of CD123 in Acute Myeloid Leukemia

Nicole M. Cruz, MD, Linda Lam, Mayumi Sugita, MD, Roman Galetto, PhD, Agnès Gouble, PhD, Julianne Smith, PhD, Gail J. Roboz, Monica L. Guzman, PhD
Journal: Blood
Blood (2016) 128 (22): 1693.
https://doi.org/10.1182/blood.V128.22.1693.1693
Published: 2016
Journal Articles

Allogeneic Tcrα/β Deficient CAR T-Cells Targeting CD123 Prolong Overall Survival of AML Patient-Derived Xenografts

Monica L. Guzman, PhD, Mayumi Sugita, MD, Hongliang Zong, MD PhD, Nathan Ewing-Crystal, Vicenta Trujillo-Alonso, Nuria Mencia-Trinchant, PhD, Linda Lam, Nicole M. Cruz, MD, Roman Galetto, PhD, Agnès Gouble, PhD, Duane C Hassane, PhD, Julianne Smith, PhD, Gail J. Roboz
Journal: Blood
Blood (2016) 128 (22): 765.
https://doi.org/10.1182/blood.V128.22.765.765
Published: 2016
Journal Articles

Interleukin 2 Receptor-α (CD25) Expression Is Associated with Shortened Overall Survival and Resistance to Induction Therapy with Plerixafor and Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

John N. Allan, MD, Gail J. Roboz, MD, Eric J. Feldman, MD, Joseph M. Scandura, MD PhD, Ellen K. Ritchie, MD, Linda Lam, Wen Xie, Hsiao-Ting Hsu, MS, Duane C Hassane, PhD, Monica L. Guzman, PhD
Journal: Blood
Blood (2014) 124 (21): 1041.
https://doi.org/10.1182/blood.V124.21.1041.1041
Published: 2014
Journal Articles

Combining Decitabine With Plerixafor Yields a High Response Rate In Newly Diagnosed Older Patients With AML

Gail J. Roboz, MD, Joseph M. Scandura, MD, PhD, Ellen Ritchie, MD, Yulia Dault, RN, Linda Lam, Wen Xie, Hsiao-Ting Hsu, Danielle Marshall, Paul J Christos, Cindy Ippoliti, Eric J. Feldman, MD, Monica L. Guzman, PhD
Journal: Blood
Blood (2013) 122 (21): 621.
https://doi.org/10.1182/blood.V122.21.621.621
Published: 2013